Lu, C., Hsiao, C., Peng, P., Huang, S., Chuang, M., Su, H., & Huang, K. (2023). DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers, 15(18), 4465. https://doi.org/10.3390/cancers15184465
Chicago Style (17th ed.) CitationLu, Chang-Yi, Chih-Yang Hsiao, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Hung-Ju Su, and Kai-Wen Huang. "DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma." Cancers 15, no. 18 (2023): 4465. https://doi.org/10.3390/cancers15184465.
MLA (9th ed.) CitationLu, Chang-Yi, et al. "DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma." Cancers, vol. 15, no. 18, 2023, p. 4465, https://doi.org/10.3390/cancers15184465.